Literature DB >> 10933381

Effects of a nitrate-free interval on tolerance, vasoconstrictor sensitivity and vascular superoxide production.

T Münzel1, H Mollnau, M Hartmann, C Geiger, M Oelze, A Warnholtz, A H Yehia, U Förstermann, T Meinertz.   

Abstract

OBJECTIVES: In the present study, we tested whether a nitrate-free interval is able to prevent increases in vascular superoxide (O2*-) and the development of hypersensitivity to vasoconstrictors and whether this may result in restoration of vascular nitroglycerin (NTG) sensitivity.
BACKGROUND: Intermittent NTG-patch treatment (12 h patch on/patch-off) has been shown to increase ischemic periods in patients with stable coronary arteries, suggesting a rebound-like situation during the patch-off period. Recently, we demonstrated that long-term treatment with NTG induces tolerance, which was in part related to increases in vascular O2*- and increased vasoconstrictor sensitivity.
METHODS: New Zealand white rabbits received a continuous application of NTG patches (0.4 mg/h) or an intermittent application of NTG patches (12 h patch on, 12 h patch off) for three days. Isometric tension studies were performed with aortic rings, and vascular O2*- was estimated using lucigenin-derived chemiluminescence (5 micromol/liter). Expression of the copper/zinc (Cu/Zn) superoxide dismutase (SOD) was assessed by Western blotting, and SOD activity was measured by autooxidation of 6-hydroxydopamine.
RESULTS: Continuous treatment with NTG caused tolerance to NTG, cross-tolerance to the endothelium-dependent vasodilator acetylcholine, increased vascular O2*-, reduced Cu/Zn SOD expression and increased sensitivity to vasoconstrictors such as phenylephrine, serotonin and angiotensin II. On/off treatment with NTG improved tolerance, corrected endothelial dysfunction and decreased vascular O2*-. In addition the reduction in SOD expression was less pronounced, whereas increases in the sensitivity to vasoconstrictors such as phenylephrine and serotonin remained nearly unchanged.
CONCLUSIONS: Enhanced vasoconstrictor sensitivity may explain, at least in part, the rebound phenomena observed in patients during a 12-h NTG patch-off period.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933381     DOI: 10.1016/s0735-1097(00)00754-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

Review 1.  Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris.

Authors:  Jason M Tarkin; Juan Carlos Kaski
Journal:  Eur Cardiol       Date:  2018-08

Review 2.  Mechanisms underlying nitrate-induced endothelial dysfunction: insight from experimental and clinical studies.

Authors:  Ascan Warnholtz; Nikolaus Tsilimingas; Maria Wendt; Thomas Münzel
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

Review 3.  Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress.

Authors:  Andreas Daiber; Thomas Münzel
Journal:  Antioxid Redox Signal       Date:  2015-09-24       Impact factor: 8.401

Review 4.  Nitrate tolerance and the links with endothelial dysfunction and oxidative stress.

Authors:  Katherine E Fayers; Michael H Cummings; Kenneth M Shaw; David W Laight
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

Review 5.  Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.

Authors:  Matthias Oelze; Swenja Schuhmacher; Andreas Daiber
Journal:  Exp Diabetes Res       Date:  2010-12-27

6.  Evaluation of possible effects of crocin against nitrate tolerance and endothelial dysfunction.

Authors:  Seyedeh Farzaneh Omidkhoda; BiBi Marjan Razavi; Mohsen Imenshahidi; Maryam Rameshrad; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2020-03       Impact factor: 2.699

Review 7.  The Role of Nicorandil in the Management of Chronic Coronary Syndromes in the Gulf Region.

Authors:  Kevin Cheng; Khaldoon Alhumood; Fayez El Shaer; Ranil De Silva
Journal:  Adv Ther       Date:  2020-12-22       Impact factor: 3.845

8.  Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic Angina.

Authors:  Yongwhan Lim; Min Chul Kim; Youngkeun Ahn; Kyung Hoon Cho; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Myung Ho Jeong; Sang Hong Baek; Sung-Ho Her; Kwan Yong Lee; Seung Hwan Han; Seung-Woon Rha; Dong-Ju Choi; Hyeon-Cheol Gwon; Hyuck Moon Kwon; Tae-Hyun Yang; Keun-Ho Park; Sang-Ho Jo
Journal:  J Am Heart Assoc       Date:  2022-03-29       Impact factor: 5.501

9.  Nitrates vs. Other Types of Vasodilators and Clinical Outcomes in Patients with Vasospastic Angina: A Propensity Score-Matched Analysis.

Authors:  Hyun-Jin Kim; Sang-Ho Jo; Min-Ho Lee; Won-Woo Seo; Hack-Lyoung Kim; Kwan Yong Lee; Tae-Hyun Yang; Sung-Ho Her; Byoung-Kwon Lee; Keun-Ho Park; Youngkeun Ahn; Seung-Woon Rha; Hyeon-Cheol Gwon; Dong-Ju Choi; Sang Hong Baek
Journal:  J Clin Med       Date:  2022-06-07       Impact factor: 4.964

Review 10.  Vasodilator Therapy: Nitrates and Nicorandil.

Authors:  Jason M Tarkin; Juan Carlos Kaski
Journal:  Cardiovasc Drugs Ther       Date:  2016-08       Impact factor: 3.727

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.